These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2877149)

  • 1. Teicoplanin-resistant coagulase-negative staphylococcus.
    Wilson AP; O'Hare MD; Felmingham D; Grüneberg RN
    Lancet; 1986 Oct; 2(8513):973. PubMed ID: 2877149
    [No Abstract]   [Full Text] [Related]  

  • 2. Teicoplanin-resistant coagulase-negative staphylococci.
    Brumeitt W; Hamilton-Miller JM; Neville LO
    Lancet; 1987 Feb; 1(8528):328. PubMed ID: 2880140
    [No Abstract]   [Full Text] [Related]  

  • 3. Teicoplanin-resistant coagulase-negative staphylococci.
    Arioli V; Pallanza R
    Lancet; 1987 Jan; 1(8523):39. PubMed ID: 2879112
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulase-negative staphylococci emerging during teicoplanin therapy and the determination of their sensitivity.
    Jones RN
    J Antimicrob Chemother; 1992 Jun; 29(6):725-7. PubMed ID: 1387134
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative evaluation of in vitro activity of teicoplanin and vancomycin against coagulase negative methicillin resistant staphylococci isolated from high-risk patients.
    Battista C; Panza N; Chiurazzi B; Romano A; Pacilio G; Amato G; Gargiulo F; Bolletti Censi M; Bocchetti M
    Biomed Pharmacother; 1991; 45(1):43. PubMed ID: 1828377
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
    Del Bene VE; John JF; Twitty JA; Lewis JW
    J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F; Bingen E; Lambert-Zechovsky N
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity.
    Chomarat M; Espinouse D; Flandrois JP
    J Antimicrob Chemother; 1991 Apr; 27(4):475-80. PubMed ID: 1830301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation of coagulase-negative teicoplanin-resistant staphylococci].
    Riegel P; Ellis A; Jehl F
    Presse Med; 1990 Jun; 19(22):1053. PubMed ID: 2141162
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
    Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
    J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci.
    Felmingham D; Solomonides K; O'Hare MD; Wilson AP; Grüneberg RN
    J Antimicrob Chemother; 1987 Oct; 20(4):609-10. PubMed ID: 2960645
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
    Boisson K; Thouverez M; Talon D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.
    Bertin M; Muller A; Bertrand X; Cornette C; Thouverez M; Talon D
    Eur J Clin Microbiol Infect Dis; 2004 May; 23(5):375-9. PubMed ID: 15112071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
    Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
    Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.
    Moore EP; Speller DC
    J Antimicrob Chemother; 1988 Apr; 21(4):417-24. PubMed ID: 2967810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
    Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
    Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Staphylococcus haemolyticus. Bacterial resistance to teicoplanin and associated morpho-structural aspects].
    Giovanetti E; Pugnaloni A; Marinelli F; Biavasco F; Biagini G
    Boll Soc Ital Biol Sper; 1989 Oct; 65(10):975-82. PubMed ID: 2533873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of teicoplanin alone and in combination with rifampicin, gentamicin or tobramycin against coagulase-negative staphylococci.
    Watanakunakorn C
    J Antimicrob Chemother; 1987 Apr; 19(4):439-43. PubMed ID: 2953706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.